Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04449042
Other study ID # IRB-P00035427
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 1, 2020
Est. completion date October 31, 2020

Study information

Verified date October 2021
Source Boston Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The COVID-19 pandemic has disrupted anesthesia care all over the world. There remains very little data on current practice patterns and patient outcomes, particularly in anesthetized children. This is a prospective observational, multi-center study to investigate airway management related outcomes in children undergoing anesthesia during this pandemic. The investigators will compare the incidence of complications (particularly hypoxemia) in patients with COVID-19 to those who are COVID-19 negative during airway management. PAWS COVID-19 Registry https://is.gd/PEDICOVID19 Registration link https://is.gd/researchrequest


Recruitment information / eligibility

Status Completed
Enrollment 14835
Est. completion date October 31, 2020
Est. primary completion date October 31, 2020
Accepts healthy volunteers No
Gender All
Age group N/A to 18 Years
Eligibility Inclusion Criteria: - Undergoing an inpatient or outpatient procedure under general anesthesia with or without regional analgesia - Undergoing a diagnostic procedure under sedation or general anesthesia - Undergoing an urgent or emergent procedure performed during and outside of the regular operating room schedule hours. Exclusion Criteria: - Age > 18 years. - Children admitted to the operating room already intubated - Children who require tracheal intubation for life-threatening conditions in the emergency department, intensive care, or hospital ward.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
airway management during sedation or general anesthesia
airway management in children receiving sedation or general anesthesia for an elective, emergency, or urgent diagnostic or surgical procedure

Locations

Country Name City State
United States Boston Children's Hopsital Boston Massachusetts

Sponsors (7)

Lead Sponsor Collaborator
Boston Children's Hospital Children's Hospital Colorado, Children's Hospital of Philadelphia, Istituto Giannina Gaslini, Lurie Children's Hospital of Chicago, Perth Children's Hospital of Western Austrailia, The Hospital for Sick Children

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary airway complications incidence of complications (particularly hypoxemia) in patients with COVID-19 to those who are COVID-19 negative during airway management throughout duration of anesthetic
Secondary airway device type of device inserted for airway control throughout duration of anesthetic
Secondary PPE the type of PPE used by anesthetists and assistants during airway management throughout duration of anesthetic
Secondary First pass success compare the first attempt success rate of tracheal intubation in patients with the disease to those without the disease during induction and intubation
Secondary induction techniques variability in practice for induction of anesthesia during induction of anesthesia
Secondary failed intubation determine the Incidence of failed intubation during induction of anesthesia
Secondary complication risk factors determine risk factors related to complications (PPE type, Location, Age, Baseline Saturation, Induction technique, clinician type) during anesthetic management
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3